Status:
COMPLETED
Vastmanland Myocardial Infarction Study (VaMIS)
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Västmanland County Council, Sweden
Conditions:
Acute Myocardial Infarction
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The main purposes of this study are: * to describe the prevalence of peripheral artery disease (including lower extremity artery disease, carotid artery disease, renal artery disease, and abdominal a...
Detailed Description
Atherosclerotic arterial disease is the main cause of premature death worldwide and is anticipated to remain the single leading cause of morbidity and mortality the following two decades. Coronary hea...
Eligibility Criteria
Inclusion
- Hospitalized at the Department of Cardiology, Central Hospital, Västerås, Sweden.
- Living in the catchment area of the Central Hospital, Västerås, Sweden.
- Diagnosis of acute myocardial infarction, i.e. a rise in serum concentration of troponin-I to \>= 0.4 microgram/Liter and its subsequent fall in combination with one of the following: a) ischaemic symptoms, b) development of Q-waves on the ECG, c) ECG-changes indicative o ischaemia (ST segment elevation or depression), or d) coronary artery intervention.
Exclusion
- age less than 18 years
- severly impaired communication capabilities
Key Trial Info
Start Date :
November 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
1008 Patients enrolled
Trial Details
Trial ID
NCT01452178
Start Date
November 1 2005
End Date
May 1 2011
Last Update
May 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Clinical Research, Uppsala University, Västmanland County Hospital
Västerås, Sweden, SE-72189